Fezolinetant
- Product Name
- Fezolinetant
- CAS No.
- 1629229-37-3
- Chemical Name
- Fezolinetant
- Synonyms
- ESN-364;Fezolinetant;Fexolinetant;FEZOLINETANT; ESN-364; ESN 364; ESN364;(S)-1-((2-((tert-butyldimethylsilyl)oxy)ethyl)amino)-2,3-dihydro-1H-indene-4-carbonitrile;Inhibitor,Neurokinin Receptor,ESN364,Tachykinin receptor,ESN 364,Fezolinetant,inhibit,NK receptor;(R)-(4-fluorophenyl)(8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanone;Methanone, [(8R)-5,6-dihydro-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl](4-fluorophenyl)-
- CBNumber
- CB43159873
- Molecular Formula
- C16H15FN6OS
- Formula Weight
- 358.39
- MOL File
- 1629229-37-3.mol
Fezolinetant Property
- Boiling point:
- 623.0±65.0 °C(Predicted)
- Density
- 1.56±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- DMSO:20.0(Max Conc. mg/mL);55.8(Max Conc. mM)
- pka
- -0.28±0.40(Predicted)
- form
- Solid
- color
- White to yellow
- InChI
- InChI=1S/C16H15FN6OS/c1-9-13-19-20-14(15-18-10(2)21-25-15)23(13)8-7-22(9)16(24)11-3-5-12(17)6-4-11/h3-6,9H,7-8H2,1-2H3/t9-/m1/s1
- InChIKey
- PPSNFPASKFYPMN-SECBINFHSA-N
- SMILES
- C(N1CCN2C(C3SN=C(C)N=3)=NN=C2[C@H]1C)(C1=CC=C(F)C=C1)=O
N-Bromosuccinimide Price
- Product number
- CS-7952
- Product name
- Fezolinetant
- Purity
- 98.16%
- Packaging
- 1mg
- Price
- $120
- Updated
- 2021/12/16
- Product number
- CS-7952
- Product name
- Fezolinetant
- Purity
- 98.16%
- Packaging
- 5mg
- Price
- $390
- Updated
- 2021/12/16
- Product number
- CS-7952
- Product name
- Fezolinetant
- Purity
- 98.16%
- Packaging
- 10mg
- Price
- $570
- Updated
- 2021/12/16
- Product number
- CS-7952
- Product name
- Fezolinetant
- Purity
- 98.16%
- Packaging
- 25mg
- Price
- $1140
- Updated
- 2021/12/16
- Product number
- CS-7952
- Product name
- Fezolinetant
- Purity
- 98.16%
- Packaging
- 50mg
- Price
- $1740
- Updated
- 2021/12/16
Fezolinetant Chemical Properties,Usage,Production
Uses
Fezolinetant is an antagonist of the neurokinin 3 receptor (NK3R), used for the treatment of menopausal hot flushes.
Definition
ChEBI: Fezolinetant is a triazolopyrazine that is 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyrazine substituted by 3-methyl-1,2,4-thiadiazol-5-yl, 4-fluorobenzoyl and methyl groups at positions 3, 7, and 8R, respectively. It is a prescription medicine used to reduce moderate to severe vasomotor symptoms due to menopause. It has a role as a neurokinin-3 receptor antagonist. It is a member of monofluorobenzenes, a triazolopyrazine, a member of thiadiazoles, a member of benzamides and a tertiary carboxamide.
Mechanism of action
Fezolinetant is an oral non-hormonal therapy that is an NK3R antagonist. It works by binding to and blocking the activity of NK3 receptors, which play a role in the regulation of body temperature in the brain.
Side effects
The common side effects of Fezolinetant include abdominal pain, diarrhoea, insomnia, back pain, hot flushes and elevated liver transaminases.
Fezolinetant Preparation Products And Raw materials
Raw materials
Preparation Products
Fezolinetant Suppliers
View Lastest Price from Fezolinetant manufacturers
- Product
- Birinapant 1629229-37-3
- Price
- US $1.00-0.50/kg
- Min. Order
- 1kg
- Purity
- 99%
- Supply Ability
- 200
- Release date
- 2024-03-21
- Product
- Fezolinetant 1629229-37-3
- Price
- US $0.00/g
- Min. Order
- 1g
- Purity
- More Than 99%
- Supply Ability
- 50kg/Month
- Release date
- 2024-07-03
- Product
- Fexolinetant 1629229-37-3
- Price
- US $0.00/g
- Min. Order
- 1g
- Purity
- More Than 99%
- Supply Ability
- 100kg/Month
- Release date
- 2024-09-25